We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,968

China SAIC launches three-month campaign against unfair competition practices with emphasis on healthcare sector
  • Sidley Austin LLP
  • China
  • August 21 2013

In mid-August 2013, China's State Administration for Industry and Commerce ("SAIC") announced a three-month nationwide campaign against unfair


New essential drugs list issued by Ministry of Health
  • HFG Law & Intellectual Property
  • China
  • April 30 2013

On 19th March, PRC Ministry of Health issued a list of essential medicine made by 317 kinds of chemical medicines and biological products and 203


CFDA seeks public comment on Special Approval Procedures for Innovative Medical Devices
  • Reed Smith LLP
  • China
  • April 26 2013

China Food and Drug Administration ("CFDA," previously known as "SFDA") issued a draft Notice on Soliciting Public Comments on the Special Approval


CFDA clarifies legal consequences of clinical trial data inspections
  • Ropes & Gray LLP
  • China
  • October 12 2016

China's recent drug regulatory reform has emphasised that clinical trial data must be authentic and reliable. However, the legal consequences for


The pitfalls of employee-created IP
  • Spruson & Ferguson
  • China
  • October 13 2016

In recent years, increasing numbers of European companies have moved research and development (R&D) activities to China. For some, their China R&D is


China introduces major changes to medical device regulations
  • Ropes & Gray LLP
  • China
  • April 1 2014

On March 31, 2014, China's State Council released the amended Regulations on the Supervision and Administration of Medical Devices (the


China’s medical device regulations take effect June 1
  • Shook Hardy & Bacon LLP
  • China
  • May 1 2014

According to news sources, China's amended medical device rules, which increase fines for illegal manufacturing and strengthen government oversight


Regulation of medical advertisements
  • Clyde & Co LLP
  • China
  • April 30 2013

With over 1.35 billion people, healthcare in China is already a huge, and growing, market. Companies seeking to develop this potential have used


More certainty, less discretion proposed new rules on administrative penalty over drug and medical equipment industry
  • King & Wood Mallesons
  • China
  • May 10 2013

On 19 September 2012, SFDA released the Rules on Imposing Administrative Penalties for Drugs and Medical Equipment (Consultative Draft) (the "Draft"


Engineered avian and swine flu hybrids raise concerns about mammal-to-mammal transmission
  • Shook Hardy & Bacon LLP
  • China
  • May 10 2013

Chinese scientists investigating the spread of airborne influenzas have reportedly combined genetic material from avian (H5N1) and swine (H1N1) flu